Related Experiment Videos
[Eukaryotic expression and functional characterization of PD-1 extracellular domain]
Yu-Fei He1, Gui-Mei Zhang, Xiao-Hong Wang
1Department of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China.
Summary
This study developed a soluble PD-1 receptor to block tumor immune evasion. This approach enhances the immune system's ability to fight cancer cells.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Context:
- Tumor immune evasion involves inhibitory signals from programmed death-1 (PD-1) and its ligands (PD-L1, PD-L2).
- Blocking these interactions is a strategy to restore anti-tumor immunity.
Purpose:
- To construct a eukaryotic expression plasmid encoding a soluble form of murine PD-1 (sPD-1).
- To evaluate the efficacy of sPD-1 in blocking PD-1/PD-L interactions and enhancing anti-tumor activity.
Summary:
- A plasmid expressing soluble PD-1 (sPD-1) was created, with most protein secreted from transfected cells.
- FACS analysis confirmed sPD-1 binds specifically to PD-1 ligands.
- Cytotoxicity assays demonstrated sPD-1 enhances the lysis of tumor cells by stimulated immune cells.
Impact:
- The developed plasmid offers a novel gene therapy approach for cancer by blocking PD-1/PD-L interactions at tumor sites.
- This method has the potential to augment anti-tumor immune responses and improve therapeutic outcomes.